Jui-ho Wang

Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Nanosized Ginger-Derived Phenolic Zingerone Obstructs Cell Cycle G2/M Progression and Initiates Apoptosis in Human Colorectal Cancer.

Nanosized Ginger-Derived Phenolic Zingerone Obstructs Cell Cycle G2/M Progression and Initiates Apoptosis in Human Colorectal Cancer.

Journal: Environmental toxicology

Published: July 23, 2024

The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study.

The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study.

Journal: The Journal of international medical research

Published: April 20, 2023

Optimal Sequence and Second-Line Systemic Treatment of Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Meta-Analysis.

Optimal Sequence and Second-Line Systemic Treatment of Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Meta-Analysis.

Journal: Journal of clinical medicine

Published: September 07, 2021

Shared decision-making and patient decision aids in choosing first-line targeted therapy for metastatic colorectal cancer in Taiwan.

Shared decision-making and patient decision aids in choosing first-line targeted therapy for metastatic colorectal cancer in Taiwan.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: June 01, 2021

The Long Noncoding RNA LOC441461 (STX17-AS1) Modulates Colorectal Cancer Cell Growth and Motility.

The Long Noncoding RNA LOC441461 (STX17-AS1) Modulates Colorectal Cancer Cell Growth and Motility.

Journal: Cancers

Published: September 22, 2020

Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST).

Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST).

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 25, 2020

Tumor sidedness and efficacy of first-line therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer: A network meta-analysis.

Tumor sidedness and efficacy of first-line therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer: A network meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: July 03, 2019

What is the predictor of surgical mortality in adult colorectal perforation? The clinical characteristics and results of a multivariate logistic regression analysis.

What is the predictor of surgical mortality in adult colorectal perforation? The clinical characteristics and results of a multivariate logistic regression analysis.

Journal: Surgery today

Published: May 09, 2016

Prospective analysis of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab plus FOLFIRI as the first-line setting: study protocol for a randomized controlled trial.

Prospective analysis of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab plus FOLFIRI as the first-line setting: study protocol for a randomized controlled trial.

Journal: Trials

Published: October 21, 2015

Prevalence and risk factors of asymptomatic colorectal diverticulosis in Taiwan.

Prevalence and risk factors of asymptomatic colorectal diverticulosis in Taiwan.

Journal: BMC gastroenterology

Published: December 19, 2014

Prevalence and risk factors of asymptomatic colorectal polyps in taiwan.

Prevalence and risk factors of asymptomatic colorectal polyps in taiwan.

Journal: Gastroenterology research and practice

Published: February 06, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026